Ruth Dubin

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoClinical Fellowship

    Collapse Overview 
    Collapse Overview
    College: Yale University, BA
    Medical School: University of California San Francisco, MD
    Internal Medicine Residency: University of Texas Southwestern
    Nephrology Fellowship: University of California San Francisco

    Dr. Dubin is an Assistant Professor in UCSF Nephrology based at the San Francisco VA Medical Center. She has studied the effects of dialysis on cardiac function and post-dialysis fatigue, vascular dysfunction, and physiological mechanisms of elevated cardiac troponin T in persons with end-stage renal disease (ESRD). With funding from a K23 and RO3, Dr. Dubin has built an ESRD cohort of 200 patients to study vascular and cardiac dysfunction in the setting of ESRD, in collaboration with Fresenius Medical Care and DaVita Research. She is a Principal Investigator(PI) in the multi-PI format on the UO1 funded by the NIDDK to study proteomics in chronic kidney disease (CKD), the PI for a study of doxycycline in advanced CKD funded by UCSF, and PI for the Dialysis Readiness, Education and Mentoring (DREAM) project, supported by Cricket Health.

    Collapse Research 
    Collapse Research Activities and Funding
    Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease
    NIH/NIDDK U01DK108809Aug 19, 2016 - Jul 31, 2021
    Role: Co-Principal Investigator
    Novel Echocardiographic Methods to Characterize Heart Failure in ESRD
    NIH/NIDDK R03DK104013Aug 1, 2015 - Jul 31, 2017
    Role: Principal Investigator
    Elucidating Pathways of Vascular Dysfunction and Myocardial Injury in ESRD
    NIH/NIDDK K23DK092354Jul 1, 2012 - Apr 30, 2017
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Dubin R, Rubinsky A. A Digital Modality Decision Program for Patients With Advanced Chronic Kidney Disease. JMIR Form Res. 2019 Feb 06; 3(1):e12528. PMID: 30724735.
      View in: PubMed
    2. Ayer A, Mills C, Donovan C, Christenson RH, Ganz P, Dubin RF. Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort. Hemodial Int. 2019 Jan; 23(1):58-68. PMID: 30724445.
      View in: PubMed
    3. Dubin RF, Whooley M, Pico A, Ganz P, Schiller NB, Meyer C. Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study. PLoS One. 2018; 13(12):e0208042. PMID: 30557359.
      View in: PubMed
    4. Dubin RF. Application of echocardiographic data in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2018 07; 27(4):283-288. PMID: 29781842.
      View in: PubMed
    5. Dubin RF, Judd S, Scherzer R, Shlipak M, Warnock DG, Cushman M, Sarnak M, Parikh C, Bennett M, Powe N, Peralta CA. Urinary Tubular Injury Biomarkers Are Associated With ESRD and Death in the REGARDS Study. Kidney Int Rep. 2018 Sep; 3(5):1183-1192. PMID: 30197985.
      View in: PubMed
    6. Guajardo I, Ayer A, Johnson AD, Ganz P, Mills C, Donovan C, Scherzer R, Shah SJ, Peralta CA, Dubin RF. Sex differences in vascular dysfunction and cardiovascular outcomes: The cardiac, endothelial function, and arterial stiffness in ESRD (CERES) study. Hemodial Int. 2018 01; 22(1):93-102. PMID: 28272770.
      View in: PubMed
    7. Dubin RF, Deo R, Bansal N, Anderson AH, Yang P, Go AS, Keane M, Townsend R, Porter A, Budoff M, Malik S, He J, Rahman M, Wright J, Cappola T, Kallem R, Roy J, Sha D, Shlipak MG. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol. 2017 01 06; 12(1):60-68. PMID: 28062676.
      View in: PubMed
    8. Dubin RF, Guajardo I, Ayer A, Mills C, Donovan C, Beussink L, Scherzer R, Ganz P, Shah SJ. Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease. Hypertension. 2016 10; 68(4):913-20. PMID: 27550915.
      View in: PubMed
    9. Dubin RF, Shah SJ. Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes? Curr Heart Fail Rep. 2016 06; 13(3):132-9. PMID: 27118234.
      View in: PubMed
    10. Unger ED, Dubin RF, Deo R, Daruwalla V, Friedman JL, Medina C, Beussink L, Freed BH, Shah SJ. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2016 Jan; 18(1):103-12. PMID: 26635076.
      View in: PubMed
    11. Dubin RF, Beatty AL, Teerlink JR, Schiller NB, Alokozai D, Johansen KL. Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease. Echocardiography. 2014 Nov; 31(10):1205-12. PMID: 24828699; PMCID: PMC4169364.
    12. Mishra RK, Dubin RF. The effects of frequent hemodialysis on left ventricular mass, volumes, and geometry. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2025-7. PMID: 24235288; PMCID: PMC3848411.
    13. Dubin RF, Beatty AL, Teerlink JR, Schiller NB, Bolger AF, Alokozai D, Peralta CA, Johansen KL. Determinants of hemodialysis-induced segmental wall motion abnormalities. Hemodial Int. 2014 Apr; 18(2):396-405. PMID: 24224868; PMCID: PMC3976813.
    14. Dubin RF, Li Y, He J, Jaar BG, Kallem R, Lash JP, Makos G, Rosas SE, Soliman EZ, Townsend RR, Yang W, Go AS, Keane M, Defilippi C, Mishra R, Wolf M, Shlipak MG. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013 Oct 22; 14:229. PMID: 24148285; PMCID: PMC4016297.
    15. Dubin RF, Teerlink JR, Schiller NB, Alokozai D, Peralta CA, Johansen KL. Association of segmental wall motion abnormalities occurring during hemodialysis with post-dialysis fatigue. Nephrol Dial Transplant. 2013 Oct; 28(10):2580-5. PMID: 23743019.
      View in: PubMed
    16. Dubin R, Li Y, Ix JH, Shlipak MG, Whooley M, Peralta CA. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study. Am Heart J. 2012 Feb; 163(2):274-9. PMID: 22305847; PMCID: PMC3273726.
    17. Peralta CA, Katz R, Shlipak M, Dubin R, DeBoer I, Jenny N, Fitzpatrick A, Koro C, Kestenbaum B, Ix J, Sarnak M, Cushman M. Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). Am J Nephrol. 2011; 34(6):512-8. PMID: 22056971; PMCID: PMC3225232.
    18. Dubin R, Owens C, Gasper W, Ganz P, Johansen K. Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension. Hemodial Int. 2011 Jul; 15(3):350-8. PMID: 21658174.
      View in: PubMed
    19. Dubin R, Cushman M, Folsom AR, Fried LF, Palmas W, Peralta CA, Wassel C, Shlipak MG. Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis. BMC Nephrol. 2011 Jan 26; 12:3. PMID: 21269477; PMCID: PMC3037849.
    20. Dubin R, Shlipak M, Li Y, Ix J, de Boer IH, Jenny N, Peralta CA. Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant. 2011 Jun; 26(6):1903-8. PMID: 21079193; PMCID: PMC3145399.